Biobank self-reported ME/CFS patients approximated the h 2 to be 0.08 with a low confidence (72)
Step-up dosage: Increase to 4 mg once daily for the next 30 days, then increase again if needed
Important safety considerations include: Thyroid monitoring : Check TSH and free T4 at baseline, then 6-8 weeks after any levothyroxine dose change or substantial weight loss
Medicare currently covers GLP-1s for type 2 diabetes, cardiovascular disease, and sleep apnea, but coverage for weight loss drugs is prohibited by law, even as GLP-1s have proved to be highly effective for this purpose (and even cost-effective, according to a recent analysis)
This therapy is designed to regulate appetite, boost metabolism, and support fat loss, all while preserving lean muscle mass
X.WangH